Skip to main content
Fig. 2 | Implementation Science

Fig. 2

From: Assessing the impact of a national clinical guideline for the management of chronic pain on opioid prescribing rates: a controlled interrupted time series analysis

Fig. 2

Prescribing time series of weak1 and strong2 opioids in Scotland, before and after the publication of SIGN 136 in December 2013 (red dashed line). The solid lines represent the prescribing trend derived from the interrupted time series analysis. 1Weak opioids are the following and their compounds: codeine, dihydrocodeine, meptazinol and tramadol. 2Strong opioids are the following and their compounds: buprenorphine, diamorphine, dipipanone, fentanyl, hydromorphone, methadone, morphine, oxycodone, papaveretum, pentazocine, pethidine and tapentadol

Back to article page